About
CBD as Heart Medicine
Areas of Focus
Categories
Cannabis & Marijuana
Team (34)
Allan Klein, MD, CM
Our Advisors
Cardiol Therapeutics
team_member
Allen Luis, MBBS, PhD
Our Advisors
Cardiol Therapeutics
team_member
Andrea B. Parker, MSc, PhD
Management Team
Cardiol Therapeutics
team_member
Andrew Hamer, MBChB
Management Team
Cardiol Therapeutics
team_member
Anne Tomalin
Management Team
Cardiol Therapeutics
team_member
Antonio Abbate, MD, PhD
Our Advisors
Cardiol Therapeutics
team_member
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
356
By Phase
PHASE3: 1PHASE2: 2PHASE1/PHASE2: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 3RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06708299Lead Sponsor
CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation
PHASE3Recruiting
110 participants
Started: Apr 7, 2025 · Completed: Oct 21, 2026
NCT05494788Lead Sponsor
Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)
PHASE2Completed
27 participants
Started: Jan 9, 2023 · Completed: Sep 6, 2024
NCT05117346Lead Sponsor
An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
PHASE1/PHASE2Completed
20 participants
Started: Dec 1, 2022 · Completed: Jun 30, 2024
NCT05180240Lead Sponsor
Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis
PHASE2Completed
109 participants
Started: Jun 22, 2022 · Completed: Feb 4, 2025
NCT04615949Lead Sponsor
Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors
PHASE2/PHASE3Terminated
90 participants
Started: Apr 30, 2021 · Completed: Nov 30, 2022
Locations (1)
Headquarters
Oakville, ON, Canada
Map
Loading map...